Announced
Completed
Financials
Sources
Tags
clinical stage biotechnology
Acquisition
Domestic
Venture Capital
Friendly
Single Bidder
Taiwan
Biotechnology
Private
Minority
Private Equity
Completed
Synopsis
Digital Mobile Venture, an investment fund, led a $100m Series D round in Acepodia, a clinical stage biotechnology company. "This financing illustrates the confidence of Acepodia's current investors in our team, our mission, and our differentiated platform, and we are extremely grateful for their support. These funds will directly promote the progression of our clinical and pre-clinical candidates and also continue the validation of our ACC and allogeneic gamma delta 2 T-cell platforms to advance the development of innovative, effective, and importantly affordable off-the-shelf allogeneic cell therapies," Sonny Hsiao, Acepodia CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.